News
-
Bala awarded NYC Hayes Innovation Prize for development of Public Health Partners Connect, a data visualization platform that helped facilitate COVID-19 and Monkeypox vaccine distribution
New York City Mayor Eric Adams, New York City Chief Technology Officer (CTO) Matthew Fraser, and Jonathan Weiner, president of the Frederick O’Reilly Hayes Prize Foundation, last night presented 15 city employees with the first NYC Hayes Innovation Prize of his administration during an awards ceremony at Gracie Mansion. The winning projects… Read MoreMar. 30, 2023
-
Serious pneumococcal infections increase the risk of heart attack, says Wiese
Patients with serious pneumococcal infections, including pneumonia and sepsis, are at a substantially increased risk of heart attack after the onset of infection according to a Vanderbilt study published in Clinical Infectious Diseases. Prior work has demonstrated that infections can potentially lead to systemic inflammatory responses that can trigger the development… Read MoreMar. 29, 2023
-
Increasing intensity of physical and occupation therapy treatment can shorten delirium duration in medical patients, says Vasilevskis
Delirium — a form of acute brain failure — affects 8-17% of older adults who present to the emergency department (ED). It is associated with adverse outcomes including higher health care use, accelerated functional decline, and increased mortality. James Jordano, Jin Han, MD, MSc, and colleagues evaluated the impact of physical… Read MoreMar. 28, 2023
-
Hatch investigates association of medical supply shortages with increased invasive lung treatment in critically ill infants
A three-year shortage of a common cannula used in young infants needing lung support forced hospitals across the United States to switch to a more invasive form of lung support, according to researchers at Monroe Carell Jr. Children’s Hospital at Vanderbilt. Published March 3 in the journal Pediatric Critical Care Medicine, the… Read MoreMar. 27, 2023
-
Halasa finds high-dose flu vaccines most effective for pediatric stem cell transplant patients
Vanderbilt was the lead site for an NIH-funded, phase 2, multicenter influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant (HCT) recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population. The study was published in the New England Journal of Medicine, and… Read MoreMar. 24, 2023
-
Self elected to American Society for Clinical Investigation: 1 of 66 VUMC faculty members to be inducted since 1974
Four Vanderbilt University Medical Center faculty members have been elected this year to membership in the American Society for Clinical Investigation (ASCI), the organization has announced. Four others from VUMC have received ASCI Council Young Physician Scientist Awards this year, and two have received ASCI Emerging Generation Awards. Founded in 1908, the… Read MoreMar. 16, 2023
-
Tennessee parents reportedly trust their children’s health care providers the most for information about vaccines, says Williams
New analyses of the latest annual Tennessee Child Health Poll conducted by the Vanderbilt Center for Child Health Policy in late 2022 has found parents across the state reporting their children’s health care providers as the most trusted source for information about vaccines. The analysis is the latest in an ongoing study of annual… Read MoreMar. 15, 2023
-
Vasilevskis develops Shed-MEDS protocol to limit unnecessary medications for overprescribed patients
An estimated one in six older adults in the United States who take multiple prescription drugs risk major drug-drug interactions and other adverse drug effects that can worsen their medical conditions, increase the likelihood of cognitive impairment and falls, and lead to hospitalization or death. Deprescribing is a systematic effort… Read MoreMar. 14, 2023
-
Self leads study on sepsis interventions for blood pressure management
Vanderbilt University Medical Center had a leading role in a large national study designed to compare two early interventions in the treatment of patients with sepsis, the body’s severe response to an uncontrolled infection. Sepsis can cause dangerously low blood pressure, which is typically treated with intravenous (IV) fluids and/or… Read MoreMar. 10, 2023
-
MYO5B genetic mutations disrupt maturation of intestinal epithelial cells, says Acra and colleagues
Mutations in the gene MYO5B cause microvillus inclusion disease (MVID), which prevents nutrient absorption in the intestines and is characterized by severe watery diarrhea that typically starts in the first hours after birth. People with MVID usually require lifelong intravenous feedings (parenteral nutrition) or small bowel transplantation. Izumi Kaji, PhD,… Read MoreMar. 9, 2023